AI Articles and Analysis in Chemicals

Over the past few years, global supply chains have faced rising complexity due to geopolitical shifts, trade barriers, and bottlenecks, which have increased the need for resiliency. In one of the recent podcasts with Emerj, Luke van der Waals, Demand-to-Deliver Value Stream Owner at SLB,  explained how these challenges are compounded by inflationary pressures, making it harder to manage margins and maintain operational efficiency. 

Over the past few years, global supply chains have faced rising complexity due to geopolitical shifts, trade barriers, and bottlenecks, which have increased the need for resiliency. In one of the recent podcasts with Emerj, Luke van der Waals, Demand-to-Deliver Value Stream Owner at SLB,  explained how these challenges are compounded by inflationary pressures, making it harder to manage margins and maintain operational efficiency. 

This interview analysis is sponsored by Arkestro and was written, edited, and published in alignment with our Emerj sponsored content guidelines. Learn more about our thought leadership and content creation services on our Emerj Media Services page.

According to research from the American Society for Biochemistry and Molecular Biology, nine out of 10 drugs fail to make it to market in the clinical trials process. Researchers in the cited studies found that 40-50% of these failures are due to a lack of clinical efficacy, meaning that the drug is not able to produce its intended effect in people, and 30% were due to unmanageable toxicity or side effects.

This interview analysis is sponsored by Arkestro and was written, edited, and published in alignment with our Emerj sponsored content guidelines. Learn more about our thought leadership and content creation services on our Emerj Media Services page.

Sanofi is a global healthcare and pharmaceutical company. Founded in 1973, it aims to unlock and maximize the potential of critical medicines, vaccines, and self-care solutions for individuals. It accomplishes this across four global business units: Specialty Care, Vaccines, General Medicines, and Consumer Healthcare. 

This interview analysis is sponsored by Deloitte and was written, edited, and published in alignment with our Emerj sponsored content guidelines. Learn more about our thought leadership and content creation services on our Emerj Media Services page.

This interview analysis is sponsored by Quantiphi and was written, edited, and published in alignment with our Emerj sponsored content guidelines. Learn more about our thought leadership and content creation services on our Emerj Media Services page.